Uveitis Treatment Market Foreseen to Exceed the US$ 1,036.0 Million Threshold by 2027 | CAGR: 6.9%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global uveitis treatment market was pegged at US$ 648.4 Mn in 2020 and is projected to display a significant 6.9% CAGR over the forecast period (2020-2027). 

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1094

Escalating prevalence of autoimmune diseases has resulted to a higher demand for uveitis treatment across the globe. Corticosteroids are nowadays being considered as a potential option for uveitis treatment, which is likely to propel the growth of the global uveitis treatment market over the projected timeline. In a study published in the Journal of Ophthalmology in 2014, it was found that around 88% of uveitis patients can be cured using sustained-release intraocular corticosteroids.

According to the Clinical Investigation Department of the Open Access Journals, in 2013, there is an ascending number of research studies on various new treatments carried out by the leading healthcare companies, as well as research institutes in the U.S. Treatments such as next-generation calcineurin inhibitors, which aid in T-cell proliferation, are also being studied at present. Furthermore, a number of innovations in treatment of uveitis were reported during 2015–2017. For instance, AbbVie Pharmaceutical Company’s HUMIRA (adalimumab) received the U.S. FDA approval in June 2016.

Browse Press Release: https://bit.ly/3h3G1Nh

Among the numerous disease types, the anterior uveitis treatment segment is projected to grow significantly in the near future, owing to the surging prevalence of chronic diseases, such as eye trauma, mumps and rubella.

North America is projected to evolve as the principal growth engine in the global uveitis treatment market over the forecast timeframe. A large number of companies in this region, with several uveitis treatment drugs currently in the pipeline, fosters market growth in this region. For instance, the EGP-437 developed by Eyegate Pharmaceuticals for the treatment of anterior uveitis successfully passed the Phase III clinical in February 2018. Various other factors contributing for growth of the market in North America are increasing prevalence of uveitis, rising aging population, and growing companies and government initiatives to reduce diseases associated with the eyes.

The Asia Pacific uveitis treatment market is poised to witness tremendous growth in the foreseeable future, owing to the growing incidence of chronic diseases, as well as increasing investments by the local companies in the development of novel biologics for uveitis treatment.

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1094

Significant Takeaways of the Global Uveitis Treatment Market:

• Among the various treatment types, the monoclonal antibodies segment is foreseen to gain major popularity over the forecast timeline, thanks to the enhanced efficacy of these drugs in uveitis treatment.
• Among disease types, the anterior uveitis is estimated to dominate the global market over the course of the next few years.
• The key players operating in the global uveitis treatment market are AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences.

Other Related Reports:

Emergency Blankets Market, by Product Type (Aluminum, Fiberglass, Wool, and Others), by Application (First Aid, Camping, Trekking, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), By Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Optical Lens Edger Market, by Type (Manual Optical Lens Edger, Automatic Optical Lens Edger, Semi-automatic Optical Lens Edger), by Application ((Eyeglass Lens, Microscope Lens, Camera Lens, Others (Telescope and Binoculars)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.